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A cellular stress-directed bistable switch controls the
crosstalk between autophagy and apoptosis†
Orsolya Kapuy,a P. K. Vinod,b Jo´zsef Mandla and Ga´bor Ba´nhegyi*a
Decision-making between life and death is one of the most important tasks of cells to maintain their
genetic integrity. While the surviving mechanism is driven by Beclin1-dependent autophagy, the suicide
processes are controlled by caspases-mediated apoptosis. Interestingly, both these processes share
regulators such as Bcl2 and influence each other through feedback loops. The physiological relevance
of the crosstalk between autophagy and apoptosis is still unclear. To gain system level insights, we have
developed a mathematical model of the autophagy–apoptosis crosstalk. Our analysis reveals that a
combination of Bcl2-dependent regulation and feedback loops between Beclin1 and caspases robustly
enforces a sequential activation of cellular responses depending upon the intensity and duration of stress
levels. The amplifying loops for caspases activation involving Beclin1-dependent inhibition of caspases and
cleavage of Beclin1 by caspases (Beclin1 $ caspases $ Beclin1; caspases - cleaved Beclin1 - caspases)
not only make the system bistable but also help to switch off autophagy at high stress levels. The
presence of an additional positive feedback loop between Bcl2 and caspases helps to maintain the
caspases activation by making the switch irreversible. Our results provide a framework for further
experiments and modelling.
Introduction
Maintaining homeostasis is crucial for the survival of multi-
cellular organisms. It depends on the ability of cells that build
up the organism to sense and respond to the intracellular and
extracellular signals. Cells are able to keep a balance between
synthesis, degradation and recycling of diﬀerent cellular com-
ponents at a physiological level.1 Autophagy plays an essential
role in promoting the cellular-survival mechanism under toler-
able stress conditions (such as transient nutrient starvation
and growth factor withdrawal) which forces the return to the
homeostatic state. However, severe or continuous stress condi-
tions stimulate the well-known apoptotic cell death pathways
leading to self-elimination.2
The Greek word ‘‘autophagy’’ means ‘‘self-eating’’ referring
to the ability of cells to ‘‘digest’’ their own parts of the cytoplasm
and intracellular organelles. Cellular components get seques-
tered into a vesicle, called autophagosome, whose contents are
then delivered to and degraded by lysosomes.3,4 Cells have
residual autophagic activity even under physiological condi-
tions; however the process gets more eﬃcient during increasing
stress levels.5 Excessive level of autophagy is also known to
cause cell death in apoptotic-deficient cells.3,4 Due to its crucial
role in controlling cellular homeostasis the turning on or oﬀ of
autophagy is tightly regulated. The crucial regulator of auto-
phagy is Beclin1, the mammalian homolog of yeast Atg6.6,7
Beclin1 forms a multiprotein complex with other molecules
(such as UVRAG, AMBRA-1, Atg14L, Bif-1, Rubicon, SLAM,
IP3R, PINK and survivin) to activate the class III phosphatidyl
inositol-3-kinase.8 Beclin1 depleted cells cannot induce the
autophagosome formation.4
The suicidal cascade typically involves the activation of a
family of cysteine proteases called caspases.2,9 First the initiator
caspases (2; 8; 9; 10) get activated which in turn cleave the
eﬀector caspases (3; 6; 7) into their active forms. Eﬀector
caspases are synthesized in inactive pro-caspase forms, and
these forms have to be cleaved at a particular residue to become
active. The cleavage of target proteins of active eﬀector caspases
during apoptosis leads to the typical biochemical and morpho-
logical changes, such as chromatin condensation, DNA
fragmentation, cell shrinkage and membrane blebbing.2,9,10
Depending on the origin of stress stimuli, caspases activa-
tion can be mediated by intrinsic or extrinsic pathways.11
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Cells respond to the stress stimuli that originated within the
cell such as DNA damage through an intrinsic pathway by
promoting the release of factors such as cytochrome c, SMAC
from the mitochondria to cytosol through membrane permea-
bilization. On the other hand, the extracellular ligand binding
to death receptors initiates the extrinsic pathway, which also
crosstalk with the intrinsic pathway.12,13
Interestingly, diﬀerent studies have revealed the existence
of a crosstalk between autophagy and apoptosis regulatory
mechanisms at the molecular level.14–17 Fig. 1 shows the
interactions among the key molecular components which are
classified based on their function into diﬀerent groups such as
apoptosis inducer, autophagy inducer and crosstalk element.
It is well known that an anti-apoptotic factor Bcl2 (B-cell
lymphoma-2) keeps the caspases in their inactive forms under
physiological conditions.10 However, recent studies provide the
evidence that Bcl2 (as well as its homologue BclXL) also inhibits
autophagy by binding to Beclin1 and forming an inactive
complex.18,19 The Beclin1-bounded form of Bcl2 is still capable
of inhibiting the caspases activation.20 Another negative regu-
lation includes cFLIP and vFLIP mediated inhibition of both
extrinsic pathway of apoptosis (through Caspase-8) and auto-
phagy (through protein conjugated enzyme, Atg3).17,21 A crucial
question arises: how the two qualitatively diﬀerent stress
responses can be regulated by the same inhibitor molecules?
Although diﬀerent experiments have shown a strict order of
activation where the survival mechanism is followed by the
suicide loop,22–28 it is still unclear how this is achieved robustly.
Another crosstalk is shown to exist through caspases-dependent
cleavage of autophagy related proteins, which terminates auto-
phagic response.17 In addition to that the cleaved proteins of
autophagy are shown to promote apoptosis.17 For instance, it is
shown that some of the caspases inhibit autophagy by cleaving
Beclin1 following interleukin-3 (IL-3) depletion.15,29 The elimi-
nation of IL-3 resulted in autophagy measured by increasing
the LC3II level in the cell, however after 8 hours the activation
of caspases was observed.16,29 Meanwhile the level of the
autophagy indicator also diminished completely due to the
Caspase-3 and -7-dependent Beclin1 cleavage.29 Beclin1 is also
cleaved during nutrient starvation, oxidative stress, treatment with
staurosporine, TRAIL-induced apoptosis and chemotherapy.15,30–32
Further, it is shown using a non-cleavable Beclin1 that full
length protein does not, but the cleaved C-fragment of Beclin1
enhances the apoptotic cell death.32 A similar regulation
involving caspases- or calpaine-dependent cleavage of other
autophagy inducer proteins such as Atg4 and Atg5 has been
reported.33,34 All these evidences support the notion that the
caspases can amplify their own activity by their eﬀect on the
autophagy-related proteins. Caspase-3 is also known to pro-
mote its own activity by cleaving proteins in the intrinsic/
extrinsic pathway such as Bcl2, inhibitors of apoptosis, Bid
and other caspases.17,35 Studies have shown that overexpres-
sion of autophagy related proteins inhibits apoptosis and while
their knockdown sensitizes the cells to apoptosis in response to
death stimuli.4,5,25 Autophagic degradation of a subunit of
active Caspase-8 has also been reported.36 These studies sug-
gest that autophagy regulators can antagonize apoptosis by
promoting autophagy or by directly inhibiting it.
In the current work, we study the characteristic features of
the autophagy–apoptosis network that is suﬃcient to enforce
and maintain the crucial cell-fate decisions. A mathematical
model of a minimal network including a system level crosstalk is
developed. Our analysis using the recent experimental findings
demonstrates how Bcl2 works together with other molecular
players in the network depending on stress levels (a) to ensure
that only one cellular response gets activated, (b) to control
transition from one cellular response to another one and (c) to
make irreversible cellular decision. We show that multiple feed-
back loops within the integrated network are required to achieve
all the desired characteristics.
Model description
Although diﬀerent molecular components and their inter-
connections in autophagy and apoptosis pathways have been
identified, there are variations in regulation depending upon
the cellular settings and nature of stress stimuli. Such diﬀer-
ences make them to work in any of these scenarios: as a
partner, antagonist and enabler.16 Our analysis mainly focuses
on the results when both autophagy and apoptosis are involved
in mutual inhibition. This leads to the situation that either one
of them is activated or sequential activation of cellular
responses depending upon the stress levels or duration. Starva-
tion, endoplasmic reticulum stress, growth factor depletion
and DNA damage are all known to give rise to such cellular
responses (Tables S1 and S2, ESI†). However, only in the case of
nutrient depletion it is shown that the mechanism requires the
Fig. 1 The regulatory components and their inter-connections in the stress-
induced autophagy–apoptosis crosstalk. The autophagy inducers, the apoptosis
inducers and the crosstalk elements are grouped together in isolated green, blue
and red boxes, respectively. The active forms of the molecules are grouped in
dark-coloured boxes, while light-coloured boxes denote the inactive forms. Solid
arrows represent biochemical reactions, dashed line shows how the molecules
can influence each other. Blocked end lines denote inhibition.
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release of Beclin1 from the inhibition of Bcl2. It is still unclear
whether other stress signals operate through Bcl2 or other
relevant targets.
We assemble based on Fig. 1 a minimal network that is
independent of identity of molecular players and it only
includes the system level feedback loops relevant to the cross-
talk between autophagy and apoptosis (Fig. 2a). It can be seen
that inducers of both processes are inhibited by crosstalk
element and stress stimuli control them by down-regulating
the crosstalk element. Autophagy and apoptosis inducers
mutually inhibit each other forming a double negative feedback
loop. Apoptosis inducers can promote their own activation by
cleaving autophagy-related proteins which not only eliminates
the negative eﬀect of autophagy on apoptosis but also generates
their cleaved products that promote apoptosis through a posi-
tive feedback loop. On the other hand autophagy can keep itself
active by inhibiting apoptosis through autophagic degradation
of apoptosis inducers. Further, apoptosis inducers can also
promote their own activation by inhibiting the crosstalk element
thereby forming another double negative feedback loop. Our
analysis focuses on the system of crosstalk between autophagy
and apoptosis that is characterized in response to starvation.
This network includes the inter-connections between Bcl2,
the autophagy inducer Beclin1 and the apoptosis inducer
caspases (called Casps in the model) (Fig. 2b). Each of these
components fall under the diﬀerent categories described
above. The crosstalk element Bcl2 is high under physiological
conditions to arrest the activation of both ‘‘self-eating’’ and
‘‘self-killing’’ pathways. However, in the presence of stress Bcl2
levels drop or they become inactive and the cell can respond to
the unfavourable conditions by autophagy and/or apoptosis
induction.19,37 The control of Bcl2 involves regulations at the
level of synthesis, degradation and activity.37 Bcl2 undergoes
post-translational modifications (such as JNK-dependent
phosphorylation38) which aid in the dissociation of the
Beclin1–Bcl2 complex. In our model, Bcl2 regulation is simpli-
fied by considering a constant rate of its synthesis and degra-
dation with stress decreasing the stability of the protein (see the
model in ESI†).
Both Beclin1 and Casps have active and inactive forms in the
model. Casps activation depends on the pro-apoptotic proteins
BAX/BAK10 (called BAX in the model). Bcl2 inhibits both
Beclin1 and BAX by forming inhibitory complexes with them
(Fig. S1, ESI†). The Bcl2–Beclin1 complex also inhibits BAX. We
consider that the release of BAX activates Casps directly instead
of its eﬀect on mitochondria (through cytochrome c release10).
While Beclin1 can be directly inactivated in two diﬀerent ways
(through inhibitory complex formation with Bcl2 and Casps-
dependent cleavage), the inactivation of Casps is solely by
Beclin1 in our model. Besides free BAX, the cleaved form of
Beclin1 also promotes Casps activation (Fig. S1, ESI†).
The stress is used as an input (bifurcation parameter) to the
model which facilitates the dissociation of both Beclin1–Bcl2
and BAX–Bcl2 complexes. In the context of this analysis we
categorized stress based on its ability to activate only autophagy or
autophagy followed by apoptosis (Table S1, ESI†). For instance, a
low concentration of rapamycin or a transient nutrient starvation
leads to only autophagy. Therefore, we classify the low concen-
tration or transient induction of stress into a category of ‘‘low
stress’’ condition. On the other hand, the sustained induction of
stress (such as 16 h long starvation) leads to autophagy followed
by apoptosis and we classify it as ‘‘high stress’’ condition.
Results
Autophagy–apoptosis transition mediated by a bistable switch
At first the contribution of Bcl2 regulation and feedback loops
in the network towards achieving a strict order of activation of
two qualitatively diﬀerent stress response mechanisms were
analyzed. Both stoichiometric binding and positive feedback
regulation present in the network are common motifs that can
provide an expeditious change in the activity of the regulated
molecule in response to a stimulus.39 To study the eﬀect of
regulatory motifs on ordering of the events we have computed
the overall steady state response of the system which is given as
a signal response curve. The input signal is the stress level
rising from zero to a high value, while the steady state level of
both Beclin1 and Casps is traced as the output of the control
network.
Fig. 2 The minimal network of stress-induced autophagy–apoptosis crosstalk.
(a) The key network motifs controlling the autophagy–apoptosis crosstalk. (b) The
wiring diagram of the Bcl2–Beclin1–Casps model. The autophagy inducer, the
apoptosis inducer and the crosstalk element are denoted by isolated green, blue
and red boxes, respectively. The active forms of the molecules are grouped in
dark-coloured boxes, while the apoptosis inducer (Casps)-cleaved form of the
autophagy inducer (Beclin1) is depicted by a light green box. Solid arrows
represent biochemical reactions, dashed line shows how the molecules can
influence each other. Blocked end lines denote inhibition.
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Fig. 3a and b shows that both Beclin1 and Casps activities
exhibit discontinuous bistable behaviour with respect to stress
levels. At lower stress levels, Beclin1 activity follows a hyper-
bolic response curve (Fig. S2a, ESI†) but as the stress level
increases the curve turns back to become a Z-shaped curve
(Fig. 3a). The initial activation of Beclin1 is the consequence of
its stress-directed stoichiometric binding to Bcl2 to form an
inactive Beclin1–Bcl2 complex. Although inhibitory stoichio-
metric complex formation is favourable under physiological
conditions, the reversible binding always generates some
Beclin1 activity which accounts for the residual autophagic
activity observed under physiological conditions.5 On the other
hand, the response curve of Casps is S-shaped with respect to
stress levels (Fig. 3b). Both the S- and Z-shaped region of the
response curves indicate that for each stress value the systems
have two possible stable steady states (solid line) separated by
an unstable state (dashed line). The one stable state represents
the active state of autophagy: Beclin1 is active, Casps are
inactive while the other stable state represents the active state
of apoptosis: Beclin1 is inactive, Casps are active. The unstable
state with intermediate levels of active Beclin1 and Casps
cannot be reached physically by the control system, thereby
resulting in a discontinuous switch between the two stable
states. It can be observed that the Casps activity occupies a
lower stable steady state until the stress level reaches the limit
point (Fig. 3b, ESI†) of stable and unstable steady states to
activate Casps. At this critical threshold, the activation of
Casps switches to the higher stable steady state, which is
accompanied by the inactivation of Beclin1 (Fig. S2b, ESI†).
This indicates that both autophagy and apoptosis cannot
coexist together during diﬀerent stress levels.
Furthermore, a portion of the S-shaped response curve of Casps
is pushed onto the negative regime of the diagram therefore the
inactivation threshold of Casps is a negative number (Fig. 3b, ESI†).
This indicates that once the Casps are turned on by the stress
signal their activity does not decrease even if the stress signal is
turned oﬀ. As the stress level decreases the activity of Casps moves
to the left of the bifurcation diagram along the upper stable steady
state and remains in an active state for the stress value equal to zero
(Fig. 3b, ESI†). This might be a desirable property for such a system
because once cells have committed to undergo apoptosis; there
should not be a possibility to go back to the surviving state.
Therefore the control system has to render the switch of Casps
activation (and Beclin1 inactivation) to be an irreversible one-way
switch. A similar characteristic can be observed for the Beclin1
response curve with a portion of it on the negative regime of
diagram (Fig. 3a, Fig. S2a, ESI†). Besides irreversible activation
of Casps this network guarantees the irreversible inactivation of
Beclin1 under continuous high stress conditions.
Further the dynamics of such a control network was also
studied by following the time evolution of the activity or level of
three main components (Bcl2, active Beclin1 and Casps) in the
presence of a continuous low or high stress level. Fig. 3c shows
the eﬀect of a sustained low stress level on the system, which
activates Beclin1 gradually by promoting the degradation of
Bcl2 and dissociation of the Beclin1–Bcl2 complex. However
Casps remain inactive because the suicide feedback loop fails
to turn on thereby protecting cells from death. If the stress
Fig. 3 The characteristic properties of the Blc2–Beclin1–Casps regulatory network. The signal-response curve of (a) Beclin1 and (b) Casps are shown with respect to the
increasing stress level. Solid lines denote stable states, while dashed line denotes the unstable state. The dynamic simulation of the model with (c) continuous
low stress conditions (stress = 0.5) and (d) continuous high stress conditions (stress = 2). The dynamics of Bcl2, active Beclin1 (free form) and Casps are shown.
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connected events can be eliminated the system returns to its
homeostatic state (data not shown). However, a constant high
level of stress has dramatic eﬀects on the system (Fig. 3d).
Beclin1 gets activated rapidly first, but under these circum-
stances the Bcl2 level diminishes completely. This facilitates
the activation of Casps by turning on the positive feedback
loop. Although Beclin1 induces autophagy and inhibits apop-
tosis, Casps can still be turned on. The increasing Casps activity
rapidly down-regulates Beclin1 by transforming it into an
inactive form. This form of Beclin1 fails to induce autophagy,
but it promotes apoptosis by Casps activation. It can be noted
that there is a short window of autophagic activity at high stress
levels. The regulatory system has a chance to rescue itself by
healing damages, but continuous intolerable stress results in
apoptosis. Such a situation is possible because of the time delay
in the appearance of Casps.
The positive feedback regulation is shown to be crucial to
establish an irreversible cell-fate decision between two qualita-
tively diﬀerent states in other systems.40,41 In the autophagy–
apoptosis crosstalk network considered here there are multiple
feedback loops which can provide this system level property.
This includes both double negative feedback loops (Beclin1 $
Casps $ Beclin1 and Casps $ Bcl2 $ Casps), and a positive
feedback loop (Casps- cleaved Beclin1- Casps) (Fig. 2b).
It is known that in the apoptosis regulatory network itself
there are diﬀerent positive feedback loops which can poten-
tially yield a bistable response.42,43 However, there is no clear
evidence for the contribution of an individual feedback loop
towards bistable response. On the other hand, the experimental
results have indicated that apoptotic inducers have to accumulate
to reach a threshold for promoting the switch-like activation of
the ‘‘self-killing pathway’’.42–47 While the contribution of diﬀerent
positive feedback loops towards bistable response remains to be
elucidated, we demonstrate that such a property can also poten-
tially arise from the crosstalk with autophagy regulation. Another
importance of such a crosstalk is the eﬃcient prevention of
autophagy, when apoptosis gets activated depending on the stress
levels. This is through a feedback loop that has a positive eﬀect on
apoptosis while a negative eﬀect on autophagy both of them
mediated through cleavage of Beclin1 by Casps.
Feedback mechanism at the crosstalk between autophagy and
apoptosis
In order to study the eﬀect of feedback loops on the steady state
and dynamics of the autophagy–apoptosis crosstalk network,
the interaction of feedback loops was systematically perturbed.
The full length Beclin1 is inhibited by Casps-dependent cleavage
and the nascent C-fragment of Beclin1 obtained after cleavage lacks
autophagic activity.29 Interestingly, translocation of Beclin1-C-
fragments into mitochondria induces apoptosis by enhancing the
release of mitochondrial pro-death factors.29 Also, non-caspase-
cleavable Beclin1 restored autophagy in BAX-overexpressed cells.32
Therefore we studied the eﬀect of modulating the Casps mediated
cleavage of Beclin1, which in principle should perturb two feedback
loops (Beclin1 $ Casps $ Beclin1 and Casps- cleaved Beclin1-
Casps) on Casps activity (Fig. 2b).
Fig. 4a shows the response curve for the situations involving
non-cleavable Beclin1 (kibc0 = 0). It can be seen that with
Fig. 4 The eﬀect of feedback loops involving Beclin1 and Casps on the network properties. (a) Signal response curve of Casps and (b) dynamics of the network are
shown with diﬀerent rates of inhibition of Beclin1 by Casps-dependent cleavage. Symbols g: kibc0 = 0, b: kibc 0 = 5 and a: kibc0 = 10 represent the situations without
inhibition, control and higher rate of inhibition of Beclin1 by Casps, respectively. (c) Signal response curve of Casps and (d) dynamics of the network are shown
with diﬀerent rates of Casps inhibition by Beclin1. Symbols a: kicp0 = 0, b: kicp0=0.35 and g: kicp0 = 0.7 represent the situations without inhibition, control and higher
rate of inhibition of Casps by Beclin1, respectively. The solid lines in the signal response curve denote stable states, while dashed line depicts the unstable state.
The temporal dynamics is simulated under continuous high stress conditions (stress = 2). The dynamics of Bcl2 and Casps are shown.
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non-cleavable Beclin1 the activation of Casps (Fig. 4a, symbol g)
is aﬀected while the activation of Beclin1 follows a hyperbolic
response curve with respect to stress levels and remains uninhi-
bited (see Fig. S3a, ESI†, symbol g). On the other hand on
increasing the Casps-dependent Beclin1 cleavage, the critical
threshold for the activation of Casps decreases to lower stress
levels (Fig. 4a, symbol a) in comparison to the control situation
(Fig. 4a, symbol b). Accordingly Beclin1 gets inhibited at lower
stress levels (Fig. S3a, ESI†, symbol a). This analysis reveals that
the bistable characteristic and the corresponding threshold for
Casps activation are influenced by Beclin1–Casps interaction.
We have also computed the dynamics under these situations
for continuous high stress conditions. Under a non-cleavable
situation, Beclin1 activity increases and remains high (Fig. S3b,
ESI†, symbol g), while Casps activity is low (Fig. 4b, symbol g).
Increasing Casps-dependent Beclin1 cleavage leads to prema-
ture activation of Casps by decreasing the time delay in its
activation (Fig. 4b, symbol a). This restricts the duration
of autophagic activity in comparison to the control situation
(Fig. S3b, ESI†, symbols a and b).
Since non-cleavable Beclin1 eliminates both feedback loops
acting on Casps, we analyzed the situation when only one
feedback loop is compromised. This can be done by removing
Beclin1-dependent inhibition of Casps (kicp0 = 0) which retains
the positive feedback regulation of Casps mediated by cleavage
of Beclin1 (Fig. 2b). In the absence of Beclin1-dependent
inhibition of Casps, the response curve of Casps is still an
irreversible bistable switch but the activation threshold of
Casps shifts to a lower threshold (Fig. 4c, symbol a) in compar-
ison to the control situation (Fig. 4c, symbol b). On the other
hand increasing the strength of this interaction completely
blocks the activation of Casps by counteracting the positive
feedback loop (Fig. 4c, symbol g), while Beclin1 activity remains
high (Fig. S3c, ESI†, symbol g). This indicates that the strength
of the positive feedback loop determines the threshold to
overcome the negative eﬀect of autophagy. Therefore in the
situation with no positive feedback loop such as non-cleavable
Beclin1, we observed Casps inactivation due to the negative
eﬀect of Beclin1 on Casps (Fig. 4a, symbol g). If the Beclin1-
dependent inhibition of Casps is weaker then a switch-like
activation of Casps can be observed (data not shown). This
suggests that the phenotype of non-cleavable Beclin1 can vary
depending on the magnitude of Beclin1-dependent inhibition
of Casps.
Fig. 4d shows the dynamic simulation in the absence
(symbol a) or hyper-activation (symbol g) of Beclin1-dependent
inhibition of Casps, which in principle resembles the situations
with hyper-activation (Fig. 4b, symbol a) or absence of (Fig. 4b,
symbol g) Beclin1 cleavage, respectively.
The analysis was also performed by retaining the double negative
feedback loop (Beclin1 $ Casps $ Beclin1) involved in Casps activa-
tion and compromising the positive feedback loop that is mediated
through the Casps-cleaved form of Beclin1 (kacp0 = 0). Experimen-
tally this mutant phenotype can be mimicked by blocking the
cleaved Beclin1-dependent apoptotic events (e.g. by blocking
the re-localization of Beclin1-C-fragments to the mitochondria).
In this mutant, the response curve of Casps shows irrever-
sible bistable behaviour with an activation threshold at higher
stress levels in comparison to the control phenotype (data not
shown).
Furthermore, we show that the bistable characteristic of the
system is not specific for the chosen parameter set but can also
be observed over the broad range of parameter values (see
Fig. S4, ESI†). In the model, the threshold for the activation of
Casps can be associated with the presence of positive feedback
loops and zero order ultrasensitivity. However, we note that the
latter condition is not a strict requirement for observing
the bistable response but can contribute towards extending
the region of bistability to higher stress levels. As the eﬀect of
zero order sensitivity is reduced by increasing the Michaelis
constant (Jcp) value of Casps activation and inactivation, the
system is still bistable but for smaller stress values.
Feedback regulation of the apoptosis pathway
Kirsch et al. (1999) have shown that Caspase-3 has a negative
eﬀect on Bcl2 thereby promoting apoptotic activation.35
Caspase-3-dependent cleavage of Bcl2 during apoptosis inhibits
the pro-apoptotic eﬀect of Bcl2.35 This creates a double negative
feedback loop in the system, where Bcl2 inhibits Casps and
Casps in turn inhibit Bcl2. We perturbed the Casps-dependent
inhibition of Bcl2 (kdb200) to study the contribution of the
double negative feedback loop on the overall response curve
of Casps (Fig. 5). We show that in the absence of Casps-
dependent Bcl2 inhibition, the irreversible bistable response
curve of Casps activation becomes reversible (Fig. 5a, symbol g
and Fig. S4, ESI†). Therefore, once Casps become active, they
can be turned oﬀ if the stress signal is eliminated. This analysis
suggests that although the interactions between Beclin1 and
Casps are suﬃcient to make the system bistable, they are
insuﬃcient to enforce the one-way directionality of the system.
In the model, the reversible characteristic of the Beclin1-Casps
bistable switch is the result of Bcl2 re-activation with the
elimination of stress. Bcl2 re-activation down-regulates both
Beclin1 and Casps activity, which is prevented in the control
situation (Fig. 5a, symbol b). However the activation threshold
for Casps (and the inactivation threshold for Beclin1) has
roughly the same value in each case (Fig. 5a, Fig. S4, ESI†).
This suggests that the mutual inhibition of Casps and Bcl2 does
not change the S-shape of the Casps response curve with
respect to stress levels, but it pushes the inactivation threshold
of Casps to the left on the diagram. Therefore increasing the
strength of the feedback loop pushes a portion of the S-shaped
curve further into the negative regime (Fig. 5a, symbol a). The
dynamic simulation shows that Casps become active after
10 hours of continuous treatment with a high stress level in
both control and in the absence of Casps-dependent inhibition
of Bcl2 (Fig. 5b). However, when the stress-dependent term is
zeroed out at 20 h, the irreversible switch maintains Casps
activity (symbol b), whereas its activity decreases in the absence
of Casps-dependent inhibition of Bcl2 (symbol g).
It is important to note that the irreversibility in the control
system prevents the cell to return to its homeostatic state only
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under continuous high stress conditions. The system can revert
back to its original state if the high stress conditions get
diminished before reaching the activation threshold of Casps.
It can be observed that if the intolerable stress is eliminated at
7.5 hours in the numerical simulation, Beclin1 remains active
(Fig. 5c). Although Bcl2 disappeared due to a high stress level
and started to turn on Casps, stress was eliminated before
Casps could get activated by helping themselves through
Beclin1-Casps feedback loops. Under these circumstances, the
re-accumulation of Bcl2 is relatively slow and therefore Beclin1
activity is high. If the duration of intolerable stress is extended
then this pushes the system to the Casps activation state and
the system cannot revert back to its original state (Fig. 5d).
These results suggest that there is a time window after which
intolerable stress turns on the irreversible switch.
The negative role of Bcl2 in the activation of both autophagy
and apoptosis pathways
We also analyzed the eﬀect of regulating the autophagy–apoptosis
crosstalk in the absence of feedback loop regulation. This
situation can be mimicked by blocking the Casps-dependent
inhibition of both Beclin1 and Bcl2. In this case, the network is
left with Bcl2 inhibition of both Beclin1 and BAX and Beclin1
inhibition of Casps. This forms an incoherent feed-forward
loop in the network, where Casps get inhibited through both
Bcl2-BAX and Beclin1 (Fig. 2b). Therefore the response curve of
Casps with respect to stress levels depends on the extent
of inhibition of Casps by both Bcl2 and Beclin1 (Fig. 6a and c).
At lower stress levels Beclin1 gets activated, since Bcl2 inhibi-
tion of Beclin1 is weaker compared to Casps (Fig. S6a, ESI†). As
the stress level increases, Casps inhibition by Bcl2 is relieved
and it becomes activated only if Beclin1 inhibition of Casps is
removed or weak. In the absence of inhibition of Casps by Beclin1,
Casps get activated at a lower stress threshold in a sigmoidal
manner (Fig. 6a, symbol a) compared to the control situation
(Fig. 6a, symbol g). However, with an increase in the inhibition of
Casps, the activation threshold moves to higher stress levels
(Fig. 6a, symbol b) and beyond a critical value it can inhibit the
activation of Casps. The dynamic simulation shows that Casps
activation is delayed with respect to Beclin1 activation (Fig. 6b,
Fig. S6b, ESI†). The time delay arises from the Bcl2 regulation of
Casps through BAX even in the absence of Beclin1 inhibition of
Casps and feedback loops in the network. This could vary depending
upon how fast Bcl2 gets inactivated by stress (Fig. 6d, symbol a)
or how fast its eﬀect reaches the eﬀector caspases through a
pathway involving several components (Fig. 6d, symbol g). The
threshold for the activation of Casps is also influenced by the
magnitude of the Bcl2 inactivation rate (Fig. 6c, symbol a) and
the Casps activation rate by BAX (Fig. 6c, symbol g). These results
suggest that the sequestration of activators by inhibitors such as
Bcl2 can contribute towards controlling the order of events.
Discussion and conclusions
Recent studies have shown that besides apoptosis autophagy is
crucial in normal human physiological processes, and defects
Fig. 5 Irreversible one-way switch of apoptosis induction. (a) The response curve of Casps and (b) dynamics of the network are shown with diﬀerent rates of Casps-
dependent inhibition of Bcl2. The temporal dynamics is simulated for 20 hours long treatment with high stress (stress = 2) depicted by a brown background. Symbols
g: kdb200 = 0, b: kdb200 = 0.1 and a: kdb200 = 0.2 represent the situations without inhibition, control and higher rate of inhibition of Bcl2 by Casps, respectively.
The solid lines in the response curve denote stable states, while dashed line depicts the unstable state. The dynamics of Bcl2 and Casps are shown. The temporal
dynamics under transient high stress conditions (stress = 2) is shown for (c) 7.5 hours long treatment and (d) 10 hours long treatment. The dynamics of Bcl2,
active Beclin1 (free form) and Casps are shown with a duration of stress depicted by a brown background.
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in autophagy can result in diﬀerent types of diseases (e.g. cancer,
neurodegeneration).3,4,14 Therefore, it is important to elucidate
the role of regulatory components involved in both autophagy
and apoptosis. A better understanding of the crosstalk between
autophagy and apoptosis may help us to stop or promote fatal
cell decisions, with the long-term aim of therapeutic interven-
tion. In this work we have explored the system level properties of
a network comprising of crosstalk between autophagy and
apoptosis using a mathematical model. Since both autophagy
and apoptosis are regulated by an integrated network, it is
diﬃcult to explore their eﬀects using a reductionist approach.
However, a computational model of the network serves as a
useful tool to predict the system response under diﬀerent
situations, which in turn can be tested using experiments. Our
first step was to build a minimal model using the crucial
components of the network to determine how the qualitative
behaviour of the system changes with respect to stress levels.
The model of crosstalk between autophagy and apoptosis
involves Bcl2-dependent inhibition of Beclin1 and BAX working
together with feedback loops involving Beclin1 and Casps. Our
analysis shows that such a minimal network is suﬃcient to turn
on robustly appropriate cell-fate decision depending on the
stress levels. We demonstrate that the stress threshold required
for Beclin1 activation (i.e. Bcl2 inactivation) should be lower
compared to Casps activation; therefore autophagy gets activated
at lower stress levels whereas Casps activation is restricted to
only higher levels of stress. It can also be seen that Casps
activation is delayed in comparison to Beclin1 activation.
Although a simple network involving only Bcl2-dependent
regulation is suﬃcient to establish a threshold and bring about
sequential activation of stress responses, our analysis suggests
that these properties can be robustly achieved in the presence
of feedback regulations between stress responses. The ampli-
fying loops involved in Casps activation (Beclin1 $ Casps $
Beclin1 and Casps- cleaved Beclin1- Casps) not only make
the system bistable but also help to switch oﬀ the autophagy at
high stress levels (Fig. 3). Such a crosstalk ensures that both
autophagy and apoptosis cannot coexist together at the same
time resulting in two discrete events. Further, a discontinuous
bistable response prevents ‘chattering’ between autophagy and
apoptosis when the stress level is fluctuating around the Casps
activation threshold. This is likely to happen with a system only
having Bcl2-dependent regulation. However, a combination of
Bcl2-dependent regulation and feedback regulation of both
Beclin1 (negative) and Casps (positive) provides a flexibility to
adapt depending on the intensity and duration of stress levels.
For example, at lower stress levels, autophagy is turned on
whereas apoptosis is suppressed by the remaining Bcl2 activity
(Fig. 3c). At intermediate stress levels, autophagy is turned on
as an initial response, which provides a time window for
survival, however apoptosis gets turned on with firing of the
positive feedback loops and inactivates autophagy (Fig. 3d). On
the other hand, at a very high stress level apoptosis turns on
instantaneously and inactivates autophagy. The time interval
between autophagy and apoptosis activation decreases with an
increase in the stress level, which controls the decay of Bcl2
activity and turning on of the feedback loops between Beclin1
and Casps.
Fig. 6 The key roles of Beclin1 and Bcl2 in Casps activation, when all the feedback loops are compromised. The eﬀect of feedback loops is removed by setting the
parameter values of kdb200 and kibc 0 to zero. (a) The response curve of Casps and (b) dynamics of network are shown with diﬀerent rates of inhibition of Casps by
Beclin1. Symbols a: kicp 0 = 0, b: kicp0 = 0.15 and g: kicp0 = 0.35 represent the situations without inhibition, low and high rate (control) of inhibition of Casps by Beclin1,
respectively. (c) The response curve of Casps and (d) dynamics of the network are shown in the absence of inhibition of Casps (symbol b: kicp 0 = 0) by Beclin1
with either increased rate of Bcl2 degradation (symbol a: kdb20 = 0.8) or decreased rate of Casps activation by BAX (symbol g: kacp00 = 0.2). The solid lines in the signal
response curve denote stable states, while dashed line depicts the unstable state. The temporal dynamics is simulated for continuous high stress conditions (stress = 2).
The dynamics of Bcl2 and Casps are shown.
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We have also shown that presence of feedback loops
between Beclin1 and Casps is insuﬃcient to stop the cells to
go back from apoptosis to survival mode with the elimination
of stress. The presence of an additional positive feedback loop
such as Bcl2 $ Casps $ Bcl2 loop35 is required to ensure
irreversible cellular decision (Fig. 5). In principle it can be
noted that Casps activation and inactivation are controlled by
feedback loops. Its activation is controlled by feedback loops
Casps - cleaved Beclin1 - Casps and Bcl2 $ Casps $ Bcl2,
while inactivation is controlled by Beclin1 $ Casps $ Beclin1.
Such a feedback regulation of opposing reactions is shown to
produce a robust all or none bistable responses.48 The two
parameter bifurcation diagrams demonstrated that only the
threshold for the activation of Casps increases or decreases
with parametric variations (Fig. S4, ESI†). This does not alter
the qualitative behaviour of the system but shifted the response
curve to lower or higher stress levels. However, we also observed
in few cases the existence of other situations such as inhibition
of apoptosis by autophagy at high stress levels (either increas-
ing kicp0 or decreasing kibc0 as shown in Fig. S4, ESI†) or
apoptosis is a sole response (increasing kacp).
Our study also shows that the key requirements for the
observed qualitative features rely on the strength of Bcl2-
dependent inhibition of Beclin1 and Casps and on the strength
of their mutual inhibition. Bcl2 indirectly controls the activa-
tion of Casps by strongly inhibiting its activator BAX in com-
parison to direct inhibition of Beclin1 (kdsbc/kasbc c kdsbx/
kasbx). Further, the inactivation rate of Beclin1 by Casps is
higher in comparison to the inactivation rate of Casps by
Beclin1 (kibc0 c kipc0). The mutual inhibition of Beclin1 and
Casps is illustrated on the phase plane computed with the
model (Fig. 7). Beclin1 nullcline shows that its steady state
concentration decreases with an increase in Casps concen-
tration due to the Casps-dependent cleavage of Beclin1. On
the other hand, Casps nullcline is Z-shaped with respect to
Beclin1 due to the positive feedback loop acting on Casps and a
high concentration of Beclin1 inhibits Casps. The intersection of
two nullclines results in two stable (autophagy and apoptosis)
and one unstable steady state. At a low level of stress the system
occupies the stable state of autophagy. However with an
increase in the stress value Casps nullcline shifts to a higher
concentration of Beclin1 and only one state is present corre-
sponding to apoptosis. Therefore the system fires to that sole
remaining stable state.
Interestingly, the apoptosis network also consists of other
explicit and implicit positive feedback loops, which might work
redundantly to enforce an irreversible bistable response.43,49,50
Similarly, the positive feedback loop through Casps mediated
cleavage of the autophagic protein not only includes Beclin1
but also other proteins such as Atg5 and Atg4.33,34 In addition
to multiple feedback loops, inhibitors are also known to
influence both autophagy and apoptosis responses. Bcl2 and
BclXL form an inhibitory complex with Beclin1 and BAX to keep
a check on both stress responses and its inhibition is relieved
in multiple ways depending upon the cellular setting and
stress.10,19,51 Besides JNK mediated regulation of the complex,
phosphorylation of Beclin1 by DAPK and binding of pro-
apoptotic proteins such as Bad is also shown to promote the
dissociation of the Beclin1–Bcl2-BclXL complex.
52,53 Further, it
is shown that Naf1 binding to Bcl2 stabilizes the Bcl2–Beclin1
interaction and inhibits autophagy.54 However, Bcl2 is not the
only inhibitor to control autophagy and apoptosis. cFLIP/vFLIP
is also known to inhibit both stress responses.21 Recently
another pro-apoptotic protein Bim1 has also been shown to
inhibit Beclin1 by sequestering it to microtubules. The disso-
ciation of the Beclin1–Bim1 complex leads to autophagy activa-
tion but also suggests that released Bim1 can translocate to
mitochondria to drive apoptosis.55 Similarly, Casps activation is
regulated by inhibitors of apoptosis such as X-linked IAP
(XIAP).56 On the other hand, several Beclin1 binding proteins
have been identified and their interactions positively influence
autophagosome formation.5 These additional layers of regula-
tion might eventually contribute towards ordering of cellular
responses depending upon stress intensity and duration.
Our analysis using the minimal model predicts the dynamics of
autophagy and apoptosis inducers when the crosstalk interactions
Fig. 7 Phase plane portrait of crosstalk between autophagy and apoptosis. Casps and Beclin1 nullclines were computed as one parameter bifurcation diagrams
and combined to create a phase plane portrait. The phase planes is shown for (a) stress = 0.25 and (b) stress = 2. Intersections of nullclines represent the
stable (filled circle) and unstable (open circle) steady states.
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are perturbed. In certain situations we show that autophagy can
overcome apoptosis or apoptosis can terminate autophagy.
Such information can be used to test (and to identify) experi-
mentally the situations that alter the balance between auto-
phagy and apoptosis. Our analysis suggests that cells might
depend on the antagonistic relationship between autophagy
and apoptosis to make timely decisions with the inactivation of
an inhibitor (crosstalk element in Fig. 1) of both processes by
diﬀerent stress stimuli (Table S2, ESI†). The decision involving
transition from autophagy to apoptosis can be addressed by the
experiments of inhibiting autophagy (e.g. by 3-methyladenine)
or using non-cleavable Beclin1 in the presence of stress stimuli,
which are predicted to bring about opposite eﬀects on the
dynamics of apoptosis activation (Fig. 4). Similarly, the non-
cleavable Beclin1 is predicted to bring about a pronounced
eﬀect on apoptosis activation than blocking the cleaved Beclin1
(Beclin1-C fragment) translocation to mitochondria.
The minimal model proposed in this work serves as a
starting point to build a comprehensive integrative model with
the availability of quantitative data. In the literature, diﬀerent
mathematical models49,50,57 have been proposed for apoptosis
but these models do not examine the influence of other
signalling cascades such as autophagy under stress. Most of the
anti-cancer drugs are known to induce autophagy in cancer cells
while autophagy inhibitors sensitize cells to chemotherapy.30
Therefore, a system level understanding requires inclusion of a
crosstalk between pathways together with feedback regulation
within individual pathways.
Methods
An ordinary diﬀerential equation (ODE) based model is used to
describe the Bcl2–Beclin1–Casps minimal network. The model is
used to explore how the qualitative behaviour of the dynamical
system changes with respect to stress levels and the role of key
motifs in the network towards enforcing these changes. The
temporal profiles and signal response curves were computed
numerical using XPP-AUT. This program is freely available from
G. Bard Ermentrout, Department of Mathematics, University
of Pittsburgh (http://www.math.pitt.edu/~bard/xpp/xpp.html).
The list of ODEs, parameter values and a detailed method for
computation are provided as part of ESI.† We also provide the
XPP code that can be used to compute the figures presented in
this work.
Abbreviations
Bcl2 B-cell lymphoma-2
Beclin1 Bcl2-interacting protein-1
Casps caspases
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